Eden Research (LON:EDEN) Trading Down 3.3% – Should You Sell?

Shares of Eden Research plc (LON:EDEN) fell 3.3% on Saturday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares were traded during mid-day trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The stock has a 50 day simple moving average of GBX 3.87 and a two-hundred day simple moving average of GBX 3.95. The stock has a market capitalization of £18.56 million, a P/E ratio of -12.19 and a beta of 0.92.

Insider Buying and Selling at Eden Research

In other Eden Research news, insider Alexander John Abrey bought 540,540 shares of Eden Research stock in a transaction dated Tuesday, January 28th. The stock was bought at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek bought 256,000 shares of Eden Research stock in a transaction dated Thursday, February 6th. The shares were acquired at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). Corporate insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.